All news

PCI-32765 is exciting news for leukaemia and lymphoma treatment

Added: Saturday 2 June 2012

Dr Susan O'Brien explains why PCI-32765 is an exciting drug for treating chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL).

+  http://www.oncologystat.com/viewpoints/commentary/PCI_32765_Is_One_of_the_Most_Exciting_Drugs_Around.html


//